Patient Pure X – PPX™
The Most Advanced Isolation Method of Autologous Exosomes
Patient Pure X™ (PPX™) is a first of its kind Concentrated Autologous Exosome Product that contains nanoparticles and proteins extracted from your own blood that can decrease elements of cellular inflammation and promote tissue healing.
Nanoparticles, such as Extracellular Vesicles (EVs), act as cell-to-cell messengers, which have several impactful effects throughout your body, delivering proteins and signature microRNA.
The signature exosomes isolated in PPX™ contain multiple types of specific microRNA markers, which target damaged cells and reduce inflammation while inducing regeneration at the cellular level, promoting long term healing and repair.
Platelet Rich Plasma (PRP) has been a therapeutic tool in the field of regenerative medicine, concentrating the platelets and growth factors for cellular and tissue repair. However, because of the lack of standardization and consistency, results can be quite variable.
PPX™ goes beyond PRP. Patient Pure X™ is an autologous blood-derived biologic that concentrates only the regenerative fraction of the patients’ blood, specifically the exosomes and other bioactive proteins. The proprietary high-speed-centrifugation process isolates an average of 400 billion nanoparticles. Once placed in the body, these powerful signature exosomes immediately begin the cascade of cellular reprogramming and tissue repair.
The specific exosomes isolated in PPX™ contain many bioactive proteins and miRNA markers which are considered the mechanism of action that reduces inflammation and induces regeneration at the cellular level.
|Concentrated plasma fraction rich in nanoparticles
|Cell reprogramming for long term physiological changes
|Cell-free, Non-HCT/P product
|FDA-compliant laboratory facility
|Tested free of microbial contamination and endotoxins
The PPX™ Processing Kit will be shipped directly to your office and includes everything you need for your patient’s blood draw procedure and the shipping materials to return overnight to our FDA registered, cGMP compliant laboratory.
Once we receive the blood sample, it is first tested for microbial contamination, and then our highly skilled team of scientists and biologists concentrate and process the exosomes utilizing high-speed centrifugation technology. In approximately one week, the final product will be shipped to the doctor’s office as 2, 1mL vials of purified and concentrated autologous exosomes.